Filing Details
- Accession Number:
- 0000950170-24-130378
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-22 19:48:02
- Reporting Period:
- 2024-11-22
- Accepted Time:
- 2024-11-22 19:48:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1582313 | Xenon Pharmaceuticals Inc. | XENE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283535 | Gary Patou | 200 - 3650 Gilmore Way Burnaby A1 V5G 4W8 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-11-22 | 3,500 | $7.38 | 27,073 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2024-11-22 | 649 | $39.80 | 26,424 | No | 4 | F | Direct | |
| Common Shares | Disposition | 2024-11-22 | 2,851 | $41.11 | 23,573 | No | 4 | S | Direct | |
| Common Shares | Acquisiton | 2024-11-22 | 3,086 | $13.48 | 26,659 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2024-11-22 | 1,046 | $39.80 | 25,613 | No | 4 | F | Direct | |
| Common Shares | Disposition | 2024-11-22 | 2,040 | $41.05 | 23,573 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2024-11-22 | 3,500 | $0.00 | 3,500 | $7.38 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2024-11-22 | 3,086 | $0.00 | 3,086 | $13.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-06-01 | No | 4 | M | Direct | |
| 0 | 2025-05-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 4,902 | Indirect | See Note |
Footnotes
- Represents the closing price of the Company's common shares on November 21, 2024 for purposes of net settlement calculations.
- By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou.
- The shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
